HK1255691A1 - 對疾病進行組織學診斷和治療的方法 - Google Patents

對疾病進行組織學診斷和治療的方法

Info

Publication number
HK1255691A1
HK1255691A1 HK18114840.3A HK18114840A HK1255691A1 HK 1255691 A1 HK1255691 A1 HK 1255691A1 HK 18114840 A HK18114840 A HK 18114840A HK 1255691 A1 HK1255691 A1 HK 1255691A1
Authority
HK
Hong Kong
Prior art keywords
diseases
treatment
methods
histological diagnosis
histological
Prior art date
Application number
HK18114840.3A
Other languages
English (en)
Inventor
郭晟
H‧Q‧李
Original Assignee
中美冠科生物技術(太倉)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中美冠科生物技術(太倉)有限公司 filed Critical 中美冠科生物技術(太倉)有限公司
Publication of HK1255691A1 publication Critical patent/HK1255691A1/zh

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK18114840.3A 2015-09-10 2018-11-20 對疾病進行組織學診斷和治療的方法 HK1255691A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2015089349 2015-09-10
CN2016079859 2016-04-21
PCT/CN2016/098593 WO2017041746A1 (en) 2015-09-10 2016-09-09 Methods for histological diagnosis and treatment of diseases

Publications (1)

Publication Number Publication Date
HK1255691A1 true HK1255691A1 (zh) 2019-08-23

Family

ID=58239537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114840.3A HK1255691A1 (zh) 2015-09-10 2018-11-20 對疾病進行組織學診斷和治療的方法

Country Status (6)

Country Link
US (1) US11640849B2 (zh)
EP (1) EP3347492B1 (zh)
JP (1) JP6895971B2 (zh)
CN (1) CN108350507B (zh)
HK (1) HK1255691A1 (zh)
WO (1) WO2017041746A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110706749B (zh) * 2019-09-10 2022-06-10 至本医疗科技（上海）有限公司 一种基于组织器官分化层次关系的癌症类型预测系统和方法
EP4094260A4 (en) * 2020-01-21 2024-02-21 Genialis Inc. ASSESSMENT OF ROBUSTNESS AND TRANSFERABILITY OF PREDICTIVE SIGNATURES ACROSS MOLECULAR BIOMARKER DATA SETS
CN115376609B (zh) * 2022-10-24 2023-03-10 广州燃石医学检验所有限公司 一种判别met基因拷贝数扩增类型的方法及装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2531967C (en) * 2003-07-10 2013-07-16 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
US20070031876A1 (en) * 2005-08-08 2007-02-08 Hsueh-Kung Lin Methods of providing gene expression profiles for metastatic cancer phenotypes utilizing differentially expressed transcripts associated with circulating tumor cells
WO2008005281A2 (en) * 2006-06-30 2008-01-10 Rosetta Inpharmatics Llc Genes associated with chemotherapy response and uses thereof
WO2008021115A2 (en) * 2006-08-14 2008-02-21 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
JP5501766B2 (ja) * 2006-11-01 2014-05-28 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン
WO2012135397A2 (en) 2011-03-29 2012-10-04 Lisanti Michael P Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
CA2854665A1 (en) * 2011-11-10 2013-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene expression signatures of neoplasm responsiveness to therapy
US20140297194A1 (en) * 2013-04-02 2014-10-02 Yih-Sheng Yang Gene signatures for detection of potential human diseases

Also Published As

Publication number Publication date
JP6895971B2 (ja) 2021-06-30
WO2017041746A1 (en) 2017-03-16
US11640849B2 (en) 2023-05-02
WO2017041746A9 (en) 2018-04-12
CN108350507A (zh) 2018-07-31
EP3347492B1 (en) 2021-03-17
JP2018532422A (ja) 2018-11-08
US20180247014A1 (en) 2018-08-30
EP3347492A1 (en) 2018-07-18
CN108350507B (zh) 2021-08-20
EP3347492A4 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
IL250686A0 (en) System and method for non-invasive analysis of subcutaneous tissue
ZA201807389B (en) Methods of treatment for cholestatic and fibrotic diseases
IL246963B (en) A method and system for evaluating the effect of medical treatment
HK1246179A1 (zh) 治療視網膜疾病的方法
ZA201807084B (en) Methods of treatment of cholestatic diseases
HK1247931A1 (zh) 用於診斷和治療癌症的組合物和方法
GB201504432D0 (en) Materials and methods for diagnosis and treatment of alzheimers disease
HUE055913T2 (hu) Módszerek és készítmények a glioblastoma diagnosztizálására és kezelésére
EP2943189A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISEASES
HK1258994A1 (zh) 用於疾病治療的方法
ZA201807390B (en) Methods of treatment for cholestatic and fibrotic diseases
EP3472181A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
HK1255691A1 (zh) 對疾病進行組織學診斷和治療的方法
GB201500875D0 (en) Antibodies for treatment and diagnosis
HK1243937A1 (zh) 治療疾病的方法
IL251135A (en) A method for the synthesis of hydroxy-triglycerides and their use for disease prevention and treatment
HK1251021A1 (zh) 診斷和治療mers相關腎病
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
GB201500555D0 (en) Method and device for the treatment of diseases
GB201621398D0 (en) Treatment of emt-associated disease
GB201404610D0 (en) Preparation and method for the treatment of skin
AU2014903232A0 (en) Method of diagnosis and treatment
AU2014903180A0 (en) Method of Diagnosis and Treatment
GB201501202D0 (en) Novel methods for diagnosis and therapy